JWJia-Ling Wang

Jia-Ling Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia-Ling Wang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Libo Zhao

    Department of Pharmacy, Peking University People’s Hospital

    2 shared publications
  • Cheng Zeng

    Department of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

    1 shared publication
  • Cheng Zeng

    Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

    1 shared publication
  • Chuan Xu

    Departments of Epidemiology and Health Statistic, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

    1 shared publication
  • Jiadao Wan

    Department of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

    1 shared publication
  • Jizhou Xiang

    Department of Pharmacology, Tongji Medical College of Huazhong Universtiy of Science and Technology

    1 shared publication

Latest Publications

  • Open Access

    2, 3, 5, 4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside Improves Gastrointestinal Motility Disorders in STZ-Induced Diabetic Mice

    by Mu-Jun Chang, Jun-Hua Xiao, Yong Wang, Yong-Li Yan, Jun Yang, Jia-Ling Wang

    Oxidative stress has recently been considered as a pivotal player in the pathogenesis of diabetic gastrointestinal dysfunction. We therefore investigated the role of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) that has a strong anti-oxidant property, in diabetic gastrointestinal dysmotility as well as the underlying protective mechanisms. THSG restored the delayed gastric emptying and the increased intestinal transit in streptozotocin (STZ)-induced diabetic mice. Loss of neuronal nitric oxide synthase (nNOS) expression and impaired nonadrenergic, noncholinergic (NANC) relaxations in diabetic mice were relieved by long-term preventive treatment with THSG. Meanwhile, THSG (10−7∼10−4 mol/L) enhanced concentration-dependently NANC relaxations of isolated colons in diabetic mice. Diabetic mice displayed a significant increase in Malondialdehyde (MDA) level and decrease in the activity of glutathione peroxidase (GSH-Px), which were ameliorated by THSG. Inhibition of caspase-3 and activation of ERK phosphorylation related MAPK pathway were involved in prevention of enhanced apoptosis in diabetes afforded by THSG. Moreover, THSG prevented the significant decrease in PPAR-γ and SIRT1 expression in diabetic ileum. Our study indicates that THSG improves diabetic gastrointestinal disorders through activation of MAPK pathway and upregulation of PPAR-γ and SIRT1.


  • Open Access

    Beneficial Effects of THSG on Acetic Acid-Induced Experimental Colitis: Involvement of Upregulation of PPAR-γ and Inhibition of the Nf-Κb Inflammatory Pathway

    by Cheng Zeng, Jun-Hua Xiao, Mu-Jun Chang, Jia-Ling Wang

    The polyphenolic compound 2,3,5,4′-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) has been shown to possess anti-inflammatory effects. Here, we examined the effects of THSG on experimental mice with colitis induced by acetic acid and whether the underlying mechanisms were associated with the PPAR-γ and NF-κB pathways. Mice were randomized into six equal groups: normal, colitis model, THSG (10, 30, 60 mg·kg−1) and mesalazine. The mice were administered 10, 30, 60 mg·kg−1 THSG or 100 mg·kg−1 mesalazine or saline once daily by intragastric administration for 7 days after induction of colitis by acetic acid irrigation. THSG dramatically attenuated acetic acid-induced colon lesions, including reversing the body weight loss and improving histopathological changes. THSG apparently decreased the increase of malondialdehyde (MDA) which is a marker of lipid peroxidation. THSG appears to exert its beneficial effects on acetic acid-induced experimental colitis through upregulation of PPAR-γ mRNA and protein levels and inhibition of the NF-κB pathway, which in turn decreases the protein overexpression of the downstream inflammatory mediators TNF-α, IL-6 and COX-2. The effect of THSG 60 mg·kg−1 on PPAR-γ mRNA expression was higher than that of mesalazine. THSG may thus be a promising new candidate or lead compound for the treatment of IBD.


  • Simultaneous determination of liensinine, isoliensinine and neferine from seed embryo of Nelumbo nucifera Gaertn. in rat plasma by a rapid HPLC method and its application to a pharmacokinetic study

    by Ying Huang, Libo Zhao, Yun Bai, Ping Liu, Jialing Wang, Jizhou Xiang

    A rapid and specific HPLC method has been developed and validated for the simultaneous determination of liensinine (CAS 2586-96-1), isoliensinine (CAS 6817-41-0) and neferine (CAS 2292-16-2) in rat plasma. The sample was prepared by a liquid-liquid extraction with diethyl ether and the recovery was above 80 % from the plasma for the three compounds. Chromatographic separation was achieved with a Hypersil BDS C18 column (4.0 mm × 250 mm, particle size 5 μm). A mobile phase consisting of methanol : 0.2 M KH2P04:0.2 M NaOH : Methylamine (71:17:12:0.002, v/v/v/v, pH 9.2-9.3) was slowly delivered at 0.8 ml/min in isocratic mode with a detection wave-length of 282 nm. The linearity of calibration curves were good (r > 0.999) in the concentration range of 0.031 -2.00 μg/ml. The lower limit of quantification can reach 0.03 μg/ml for the three compounds. The intra-day and inter-day variations estimated with QC samples were less than 8 % for the three tested concentration levels. This developed method was applied in the plasma pharmacokinetic study of total bisbenzylisoquinoline alkaloids (TAL) of the lotus flower (Lian Zi Xin) following a single oral and intravenous administration of TAL in rats.


  • Effects of neferine on the pharmacokinetics of amiodarone in rats

    by Jiadao Wan, Libo Zhao, Chuan Xu, Shaohui Zhang, Zhixin Zhang, Cheng Zeng, Mujun Chang, Junhua Xiao, Jialing Wang

    Amiodarone, an iodinated benzofuran derivative with predominantly class III anti‐arrhythmic effects, is used to treat supraventricular and ventricular arrhythmias. The purpose of this study was to assess the potential of neferine, an effective anti‐pulmonary fibrosis drug isolated from the embryo of Nelumbo nucifera Gaertner's seeds, to alter the pharmacokinetic profile of amiodarone. Experimental Sprague–Dawley rats were randomly divided into two groups. In groups 1 and 2, amiodarone was given to rats by intragastric and intravenous administration, respectively, while neferine was co‐administratered by intragastric administration. Blood samples were collected from the orbital venous plexus at indicated time points and were analyzed for amiodarone concentration using RP‐HPLC. The geometric mean ratio for Cmax and AUC0–96 was calculated. There were no significant differences between the pharmacokinetics parameters of amiodarone administered intravenously or intragastrically and the control (without neferine) group (with ratios of 0.7–1.4 in all experimental groups), suggesting that neferine had no effect on amiodarone plasma pharmacokinetics. The dosage regimen of amiodarone does not need to be taken into consideration when combined with neferine. Copyright © 2010 John Wiley & Sons, Ltd.


  • Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo

    by Shao-Hui Zhang, Wen-Quan Wang, Jia-Ling Wang

    Aim: Methods: Results: Conclusion: